Shane Ward, COO & CLO at Cidara Therapeutics, Inc. (CDTX), sold 40,041 shares at $220.08 ($5.5M) on 2025-12-10, disclosed to the SEC on 2025-12-12.
Open-market sale of $5.5M CDTX by COO & CLO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.20 | 15,041 | $33K | 0.6% |
| 2 | $219.60 | 15,041 | $3.3M | 59.8% |
| 3 | $220.08 | 9,959 | $2.2M | 39.6% |
| Total | $138.05 avg | 40,041 | $5.5M | 100% |
| Filing → |
| CDTX | SELL | 2023-03-13 | $7K | — | Filing → |
| BLCM | BUY | 2019-08-30 | $10K | — | Filing → |
| VSAR | SELL | 2018-02-12 | $7K | — | Filing → |